Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 0.72 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.72 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.72 |
| ▸ | PTGER2 | P43116 | 6/20 | 0.40 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.40 |
| ▸ | PTGER3 | P43115 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Jasmonate SCHEMBL1301885 | 1.00 | AKR1C4 (0.72) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 | |
| Methyl Jasmonate SCHEMBL14446250 | 1.00 | AKR1C4 (0.72) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 | |
| Methyl Jasmonate SCHEMBL2496795 | 1.00 | AKR1C4 (0.72) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 | |
| Methyl Jasmonate SCHEMBL36184 | 1.00 | AKR1C4 (0.72) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 | |
| Methyl Jasmonate SCHEMBL18853816 | 1.00 | AKR1C4 (0.72) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 | |
| Methyl Jasmonate SCHEMBL23196389 | 1.00 | AKR1C4 (0.72) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 | |
| Methyl Jasmonate SCHEMBL1301883 | 1.00 | AKR1C4 (0.72) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 | |
| (-)-Jasmonic Acid SCHEMBL36186 | 1.00 | AKR1C4 (0.72) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 | |
| Methyl Jasmonate SCHEMBL14446196 | 1.00 | AKR1C4 (0.72) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 | |
| Methyl-7-Epi-Jasmonate SCHEMBL1302100 | 1.00 | AKR1C4 (0.72) | AKR1C4AKR1C3AKR1C2PTGER2PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| US-20180004875-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2018-01-04 | — | — | US | claimed |
| US-20170333591-A9 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2017-11-23 | — | — | US | claimed |
| US-20170249408-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2017-08-31 | — | — | US | claimed |
| US-20170249407-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2017-08-31 | — | — | US | claimed |
| US-20160296656-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | PROCTER & GAMBLE (US) | 2016-10-13 | — | — | US | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090558-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089462-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089318-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170249408-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | LPO, QDPR, TYR | AKR1C4 502/4885AKR1C3 732/4885AKR1C2 786/4885 |
| US-20170249407-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | LPO, QDPR, TYR | AKR1C4 509/4885AKR1C3 711/4885AKR1C2 812/4885 |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | LPO, QDPR, TYR | AKR1C4 502/4885AKR1C3 732/4885AKR1C2 786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.